
Please click here for the full flyer
The A*STAR Investigatorships aim to support and promote the early independent career development of the next generation of world leaders in scientific research.
Eligibility: Applicants should have obtained their PhD not more than 48 months prior to the application date, and should have already demonstrated a strong ability and creativity in research. Applicants with MD-PhD should be in their last year of, or have completed their clinical specialty training at the time of application.
Tenability: The award provides for an independent position for a duration of 3+3 years, with a review at the end of the 2nd year and a possibility of "fast-track" promotion. Tenable at one of A*STAR's prestigious biomedical research institutes, A*STAR Investigators may select a mentor from A*STAR but will conduct and publish their research independently.
Funding: A*STAR Investigators will receive attractive remuneration, support for set-up costs, research funding, research staff and have access to state-of-the-art scientific equipment and facilities, including the Biopolis Shared Facilities and the Biological Resource Centre. Each A*STAR Investigator's laboratory will be funded with up to US$500K p.a.
Research Focuses:
- Bioimaging
- Biosensors and Biodevices
- Cell and Tissue Engineering
- Computational Biology in Systems Modeling or Transcriptional Regulation
- Discovery of Biomolecular Mechanisms using Theoretical Approaches
- Drug and Gene Delivery
- Epigenetic Regulation of Gene Expression
- Epithelial Biology
- Metabolic Medicine
- Molecular and Cellular Human Immunology
- Neuroscience
- Pharmaceuticals Synthesis and Nanobiotechnology
- Stem Cells
Closing Date: 31 May 2009
A*STAR Investigatorship Selection Panel:
1. Professor Tadataka Yamada, President, Global Health Program, Bill and Melinda Gates Foundation
2. Professor Sir David Lane, Chief Scientist, A*STAR; Chief Scientist, Cancer Research UK
3. Professor Edward Holmes, Executive Deputy Chairman, Translational and Clinical Sciences, Biomedical Research Council, A*STAR; Executive Chairman, National Medical Research Council, Singapore
4. Professor Alex Matter, Chief Executive Officer, Experimental Therapeutics Centre (ETC), A*STAR
Shortlisted candidates will be invited to Singapore for interviews and a review based on a scientific presentation, expected to be held in September 2009.
Application Instructions: Please submit 1 hard copy and 1 soft copy of the following documents by 31 May 2009:
1. CV
2. 3 letters of reference from academic referees
A*STAR Investigatorships
Agency for Science, Technology & Research,
20 Biopolis Way, #08-01, Centros,
Singapore 138668, Singapore
Email: A-STAR_ADMIN_BMRC@a-star.edu.sg
www.a-star.edu.sg/astar_investigators_bms